Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis.

Appl Environ Microbiol

Department of Microbiology and Immunology, University of Otago, P.O. Box 56, Dunedin, New Zealand.

Published: February 2006

Streptococcus uberis is one of the principal causative agents of bovine mastitis. In this study, we report that S. uberis strain 42 produces a lantibiotic, nisin U, which is 78% identical (82% similar) to nisin A from Lactococcus lactis. The 15.6-kb nisin U locus comprises 11 open reading frames, similar in putative functionality but differing in arrangement from that of the nisin A biosynthetic cluster. The nisin U producer strain exhibits specific resistance (immunity) to nisin U and cross-resistance to nisin A, a finding consistent with the 55% sequence similarity of their respective immunity peptides. Homologues of the nisin U structural gene were identified in several additional S. uberis strains, and in each case cross-protective immunity was expressed to nisin A and to the other producers of nisin U and its variants. To our knowledge, this is the first report both of characterization of a bacteriocin by S. uberis, as well as of a member of the nisin family of peptides in a species other than L. lactis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1392965PMC
http://dx.doi.org/10.1128/AEM.72.2.1148-1156.2006DOI Listing

Publication Analysis

Top Keywords

nisin
12
streptococcus uberis
8
uberis
5
molecular genetic
4
genetic characterization
4
characterization novel
4
novel nisin
4
nisin variant
4
variant produced
4
produced streptococcus
4

Similar Publications

In Vitro Insights into Bacteriocin-Mediated Modulation of Chicken Cecal Microbiota.

Int J Mol Sci

January 2025

Food Science Department, Food and Agriculture Faculty, Université Laval, Quebec, QC G1V 0A6, Canada.

Reducing the use of antibiotics in animal husbandry is essential to limit the spread of resistance. A promising alternative to antibiotics resides in bacteriocins, which are antimicrobial peptides produced by bacteria showing a great diversity in terms of spectrum of activity, structure, and mechanism of action. In this study, the effects of diverse bacteriocins on the composition and metabolic activity of chicken cecal microbiota were examined in vitro, in comparison with antibiotics.

View Article and Find Full Text PDF

Alicyclobacillus spp. are crucial factors affecting the quality of fruit juice, so it is very important to control their contamination. In this study, the inactivation activity and mechanism of high-voltage pulsed electric fields (HVPEF) combined with antibacterial agents against Alicyclobacillus spp.

View Article and Find Full Text PDF

This work aimed to study the production, for the first time, of three fermented products of chestnut puree (CP) with milk kefir grains, a higher nisin-producing (Lactococcus (L.) lactis CECT 539) and a higher lactic acid-producing (Lactobacillus (Lb.) casei CECT 4043) lactic acid bacteria (LAB).

View Article and Find Full Text PDF

In order to address the issue of food contamination by microorganisms and effectively harness the antibacterial properties of nisin, we attempted to incorporate nisin into natural polymer films while addressing its inherent instability. An antibacterial food packaging film based on carboxymethyl chitosan (CCS) binding with L-cysteine (CYS) and oxidized konjac glucomannan (OKG) was developed through both Schiff base reaction and addition reaction of thiol aldehyde. To analyze the effect of addition reaction of thiol aldehyde on the CCS-CYS/OKG films' physicochemical properties, the CCS-CYS was prepared with different CYS combination rates, which were further used to fabricate composite films.

View Article and Find Full Text PDF

Nisin A Treatment to Protect Honey Bee Larvae from European Foulbrood Disease.

Probiotics Antimicrob Proteins

January 2025

Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture, Setagaya, Tokyo, 156-8502, Japan.

European foulbrood (EFB) is a bee larvae-specific infectious disease and the causative pathogen is Melissococcus plutonius. Broad-spectrum antibiotics have classically been used in many countries to control the pathogens; however, their use in apiaries was discontinued in several countries due to concerns regarding the health of bees and humans. Therefore, the development of alternative treatments for use in apiaries that are safe for bees and humans is essential.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!